🇺🇸 FDA
Patent

US 7777036

Heterocyclic derivatives and their use as therapeutic agents

granted A61PA61P1/16A61P1/18

Quick answer

US patent 7777036 (Heterocyclic derivatives and their use as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P1/16, A61P1/18, A61P15/08, A61P17/00